|
Restenosis
Citations 191-200 of 538 total displayed.
|
Past content
(since Jan 1999):
|
- Editorials
Economics of Sirolimus-Eluting Stents: Drug-Eluting Stents Have Really Arrived
- William S. Weintraub
Circulation 2004;110:472-474, doi:10.1161/01.CIR.0000136820.77558.B1
[Full text]
- Coronary Heart Disease
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial
- David J. Cohen, Ameet Bakhai, Chunxue Shi, Louise Githiora, Tara Lavelle, Ronna H. Berezin, Martin B. Leon, Jeffrey W. Moses, Joseph P. Carrozza, Jr, James P. Zidar, Richard E. Kuntz on behalf of the SIRIUS Investigators
Circulation 2004;110:508-514; published online before print as doi:10.1161/01.CIR.0000136821.99814.43
[Abstract]
[Full text]
- Coronary Heart Disease
Clinical and Economic Outcomes of Percutaneous Coronary Interventions in the Elderly: An Analysis of Medicare Claims Data
- Mary Ann Clark, Ameet Bakhai, Michael J. Lacey, Elise M. Pelletier, and David J. Cohen
Circulation 2004;110:259-264; published online before print as doi:10.1161/01.CIR.0000135589.85501.DB
[Abstract]
[Full text]
- Coronary Heart Disease
Celecoxib, a Cyclooxygenase-2 Inhibitor, Reduces Neointimal Hyperplasia Through Inhibition of Akt Signaling
- Han-Mo Yang, Hyo-Soo Kim, Kyung-Woo Park, Hyun-Jeong You, Soo-In Jeon, Seock-Won Youn, Sung-Hwan Kim, Byung-Hee Oh, Myoung-Mook Lee, Young-Bae Park, and Kenneth Walsh
Circulation 2004;110:301-308; published online before print as doi:10.1161/01.CIR.0000135467.43430.16
[Abstract]
[Full text]
- Articles
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses. Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial
- David J. Cohen, Ameet Bakhai, Chunxue Shi, Louise Githiora, Tara Lavelle, Ronna H. Berezin, Martin B. Leon, Jeffrey W. Moses, Joseph P. Carrozza, Jr, James P. Zidar, Richard E. Kuntz on behalf of the SIRIUS Investigators
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000136821.99814.43
[Abstract]
- Articles
Celecoxib, a Cyclooxygenase-2 Inhibitor, Reduces Neointimal Hyperplasia Through Inhibition of Akt Signaling
- Han-Mo Yang, Hyo-Soo Kim, Kyung-Woo Park, Hyun-Jeong You, Soo-In Jeon, Seock-Won Youn, Sung-Hwan Kim, Byung-Hee Oh, Myoung-Mook Lee, Young-Bae Park, and Kenneth Walsh
Circulation published July 6, 2004, doi:10.1161/01.CIR.0000135467.43430.16
[Abstract]
- Coronary Heart Disease
Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents: An Alternative Strategy for Inhibition of Restenosis
- Dirk H. Walter, Manfred Cejna, Larry Diaz-Sandoval, Sean Willis, Laura Kirkwood, Peter W. Stratford, Anne B. Tietz, Rudolf Kirchmair, Marcy Silver, Cindy Curry, Andrea Wecker, Young-Sup Yoon, Regina Heidenreich, Allison Hanley, Marianne Kearney, Fermin O. Tio, Patrik Kuenzler, Jeffrey M. Isner, and Douglas W. Losordo
Circulation 2004;110:36-45; published online before print as doi:10.1161/01.CIR.0000133324.38115.0A
[Abstract]
[Full text]
- Articles
Clinical and Economic Outcomes of Percutaneous Coronary Interventions in the Elderly. An Analysis of Medicare Claims Data
- Mary Ann Clark, Ameet Bakhai, Michael J. Lacey, Elise M. Pelletier, and David J. Cohen
Circulation published June 28, 2004, doi:10.1161/01.CIR.0000135589.85501.DB
[Abstract]
- Articles
Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents. An Alternative Strategy for Inhibition of Restenosis
- Dirk H. Walter, Manfred Cejna, Larry Diaz-Sandoval, Sean Willis, Laura Kirkwood, Peter W. Stratford, Anne B. Tietz, Rudolf Kirchmair, Marcy Silver, Cindy Curry, Andrea Wecker, Young-Sup Yoon, Regina Heidenreich, Allison Hanley, Marianne Kearney, Fermin O. Tio, Patrik Kuenzler, Jeffrey M. Isner, and Douglas W. Losordo
Circulation published June 21, 2004, doi:10.1161/01.CIR.0000133324.38115.0A
[Abstract]
- Focused Perspectives
Does Heparin Cofactor II Modulate Atherosclerosis and Restenosis?
- Douglas M. Tollefsen
Circulation 2004;109:2682-2684, doi:10.1161/01.CIR.0000130436.14464.FC
[Full text]
|
|
